063 Survival in Rheumatoid Lung Disease is Longer in Patients Treated with Rituximab than in those Receiving Anti-Tumour Necrosis Factor Therapy
Keyword(s):
2016 ◽
Vol 10
(12)
◽
pp. 1453-1454
◽
2006 ◽
Vol 99
(6)
◽
pp. 391-397
◽
Keyword(s):
2018 ◽
Vol 67
(6)
◽
pp. 738-744
◽
Keyword(s):
2010 ◽
Vol 31
(1)
◽
pp. 20-34
◽
2008 ◽
Vol 20
(2)
◽
pp. 138-144
◽
Keyword(s):
2018 ◽
Vol 43
(5)
◽
pp. 577-578
◽